Hidtil ukendte spiroforbindelser med neuropeptid Y antagonistaktivitet

Spiro compounds of the general formula (I):whereinAr1 represents an optionally substituted aryl or heteroaryl;n represents 0 or 1;T, U, V and W each represent a nitrogen atom or an optionally substituted methine group, wherein at least two of which represent said methine group;X represents nitrogen;...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KANATANI, AKIO BANYU PHARMACEUTICAL CO. LTD, ISHIHARA, AKANE BANYU PHARMACEUTICAL CO., LTD, ITOH, TAKAHIRO BANYU PHARMACEUTICAL CO., LTD, FUKAMI, TAKEHIRO BANYU PHARMACEUTICAL CO., LTD, ISHII, YASUYUKI BANYU PHARMACEUTICAL CO., LTD, SAKAMOTO, TOSHIHIRO BANYU PHARMACEUTICAL CO., LTD, HAGA, YUJI BANYU PHARMACEUTICAL CO., LTD, TAKAHASHI, TOSHIYUKI BANYU PHARMACEUTICAL CO., LTD
Format: Patent
Sprache:dan
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KANATANI, AKIO BANYU PHARMACEUTICAL CO. LTD
ISHIHARA, AKANE BANYU PHARMACEUTICAL CO., LTD
ITOH, TAKAHIRO BANYU PHARMACEUTICAL CO., LTD
FUKAMI, TAKEHIRO BANYU PHARMACEUTICAL CO., LTD
ISHII, YASUYUKI BANYU PHARMACEUTICAL CO., LTD
SAKAMOTO, TOSHIHIRO BANYU PHARMACEUTICAL CO., LTD
HAGA, YUJI BANYU PHARMACEUTICAL CO., LTD
TAKAHASHI, TOSHIYUKI BANYU PHARMACEUTICAL CO., LTD
description Spiro compounds of the general formula (I):whereinAr1 represents an optionally substituted aryl or heteroaryl;n represents 0 or 1;T, U, V and W each represent a nitrogen atom or an optionally substituted methine group, wherein at least two of which represent said methine group;X represents nitrogen;Y represents an optionally substituted imino or oxygen atom, which exhibit neuropeptide Y receptor (NPY) antagonistic activities and are useful as agents for the treatment of various diseases related to NPY, for example, cardiovascular disorders, central nervous system disorders, metobolic diseases and the like.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK1204663TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK1204663TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK1204663TT33</originalsourceid><addsrcrecordid>eNqNyrENwjAQBVA3FAjY4TIAEmCUBUKiSLRuqCKDf9Ap4WzZF-aHggGoXvPWpus5KM-0TJCgoJI4xzHmO0vAXJDphUCCJceEpBzoRl7UP6NwUT8pv1mhW7Ma_bfvfm5M1bWu6fdIcUBJ_gGBDpfr8XQ417V1ztp_zge3ejUO</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Hidtil ukendte spiroforbindelser med neuropeptid Y antagonistaktivitet</title><source>esp@cenet</source><creator>KANATANI, AKIO BANYU PHARMACEUTICAL CO. LTD ; ISHIHARA, AKANE BANYU PHARMACEUTICAL CO., LTD ; ITOH, TAKAHIRO BANYU PHARMACEUTICAL CO., LTD ; FUKAMI, TAKEHIRO BANYU PHARMACEUTICAL CO., LTD ; ISHII, YASUYUKI BANYU PHARMACEUTICAL CO., LTD ; SAKAMOTO, TOSHIHIRO BANYU PHARMACEUTICAL CO., LTD ; HAGA, YUJI BANYU PHARMACEUTICAL CO., LTD ; TAKAHASHI, TOSHIYUKI BANYU PHARMACEUTICAL CO., LTD</creator><creatorcontrib>KANATANI, AKIO BANYU PHARMACEUTICAL CO. LTD ; ISHIHARA, AKANE BANYU PHARMACEUTICAL CO., LTD ; ITOH, TAKAHIRO BANYU PHARMACEUTICAL CO., LTD ; FUKAMI, TAKEHIRO BANYU PHARMACEUTICAL CO., LTD ; ISHII, YASUYUKI BANYU PHARMACEUTICAL CO., LTD ; SAKAMOTO, TOSHIHIRO BANYU PHARMACEUTICAL CO., LTD ; HAGA, YUJI BANYU PHARMACEUTICAL CO., LTD ; TAKAHASHI, TOSHIYUKI BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><description>Spiro compounds of the general formula (I):whereinAr1 represents an optionally substituted aryl or heteroaryl;n represents 0 or 1;T, U, V and W each represent a nitrogen atom or an optionally substituted methine group, wherein at least two of which represent said methine group;X represents nitrogen;Y represents an optionally substituted imino or oxygen atom, which exhibit neuropeptide Y receptor (NPY) antagonistic activities and are useful as agents for the treatment of various diseases related to NPY, for example, cardiovascular disorders, central nervous system disorders, metobolic diseases and the like.</description><edition>7</edition><language>dan</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040209&amp;DB=EPODOC&amp;CC=DK&amp;NR=1204663T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040209&amp;DB=EPODOC&amp;CC=DK&amp;NR=1204663T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KANATANI, AKIO BANYU PHARMACEUTICAL CO. LTD</creatorcontrib><creatorcontrib>ISHIHARA, AKANE BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><creatorcontrib>ITOH, TAKAHIRO BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><creatorcontrib>FUKAMI, TAKEHIRO BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><creatorcontrib>ISHII, YASUYUKI BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><creatorcontrib>SAKAMOTO, TOSHIHIRO BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><creatorcontrib>HAGA, YUJI BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><creatorcontrib>TAKAHASHI, TOSHIYUKI BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><title>Hidtil ukendte spiroforbindelser med neuropeptid Y antagonistaktivitet</title><description>Spiro compounds of the general formula (I):whereinAr1 represents an optionally substituted aryl or heteroaryl;n represents 0 or 1;T, U, V and W each represent a nitrogen atom or an optionally substituted methine group, wherein at least two of which represent said methine group;X represents nitrogen;Y represents an optionally substituted imino or oxygen atom, which exhibit neuropeptide Y receptor (NPY) antagonistic activities and are useful as agents for the treatment of various diseases related to NPY, for example, cardiovascular disorders, central nervous system disorders, metobolic diseases and the like.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrENwjAQBVA3FAjY4TIAEmCUBUKiSLRuqCKDf9Ap4WzZF-aHggGoXvPWpus5KM-0TJCgoJI4xzHmO0vAXJDphUCCJceEpBzoRl7UP6NwUT8pv1mhW7Ma_bfvfm5M1bWu6fdIcUBJ_gGBDpfr8XQ417V1ztp_zge3ejUO</recordid><startdate>20040209</startdate><enddate>20040209</enddate><creator>KANATANI, AKIO BANYU PHARMACEUTICAL CO. LTD</creator><creator>ISHIHARA, AKANE BANYU PHARMACEUTICAL CO., LTD</creator><creator>ITOH, TAKAHIRO BANYU PHARMACEUTICAL CO., LTD</creator><creator>FUKAMI, TAKEHIRO BANYU PHARMACEUTICAL CO., LTD</creator><creator>ISHII, YASUYUKI BANYU PHARMACEUTICAL CO., LTD</creator><creator>SAKAMOTO, TOSHIHIRO BANYU PHARMACEUTICAL CO., LTD</creator><creator>HAGA, YUJI BANYU PHARMACEUTICAL CO., LTD</creator><creator>TAKAHASHI, TOSHIYUKI BANYU PHARMACEUTICAL CO., LTD</creator><scope>EVB</scope></search><sort><creationdate>20040209</creationdate><title>Hidtil ukendte spiroforbindelser med neuropeptid Y antagonistaktivitet</title><author>KANATANI, AKIO BANYU PHARMACEUTICAL CO. LTD ; ISHIHARA, AKANE BANYU PHARMACEUTICAL CO., LTD ; ITOH, TAKAHIRO BANYU PHARMACEUTICAL CO., LTD ; FUKAMI, TAKEHIRO BANYU PHARMACEUTICAL CO., LTD ; ISHII, YASUYUKI BANYU PHARMACEUTICAL CO., LTD ; SAKAMOTO, TOSHIHIRO BANYU PHARMACEUTICAL CO., LTD ; HAGA, YUJI BANYU PHARMACEUTICAL CO., LTD ; TAKAHASHI, TOSHIYUKI BANYU PHARMACEUTICAL CO., LTD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK1204663TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>2004</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KANATANI, AKIO BANYU PHARMACEUTICAL CO. LTD</creatorcontrib><creatorcontrib>ISHIHARA, AKANE BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><creatorcontrib>ITOH, TAKAHIRO BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><creatorcontrib>FUKAMI, TAKEHIRO BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><creatorcontrib>ISHII, YASUYUKI BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><creatorcontrib>SAKAMOTO, TOSHIHIRO BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><creatorcontrib>HAGA, YUJI BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><creatorcontrib>TAKAHASHI, TOSHIYUKI BANYU PHARMACEUTICAL CO., LTD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KANATANI, AKIO BANYU PHARMACEUTICAL CO. LTD</au><au>ISHIHARA, AKANE BANYU PHARMACEUTICAL CO., LTD</au><au>ITOH, TAKAHIRO BANYU PHARMACEUTICAL CO., LTD</au><au>FUKAMI, TAKEHIRO BANYU PHARMACEUTICAL CO., LTD</au><au>ISHII, YASUYUKI BANYU PHARMACEUTICAL CO., LTD</au><au>SAKAMOTO, TOSHIHIRO BANYU PHARMACEUTICAL CO., LTD</au><au>HAGA, YUJI BANYU PHARMACEUTICAL CO., LTD</au><au>TAKAHASHI, TOSHIYUKI BANYU PHARMACEUTICAL CO., LTD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Hidtil ukendte spiroforbindelser med neuropeptid Y antagonistaktivitet</title><date>2004-02-09</date><risdate>2004</risdate><abstract>Spiro compounds of the general formula (I):whereinAr1 represents an optionally substituted aryl or heteroaryl;n represents 0 or 1;T, U, V and W each represent a nitrogen atom or an optionally substituted methine group, wherein at least two of which represent said methine group;X represents nitrogen;Y represents an optionally substituted imino or oxygen atom, which exhibit neuropeptide Y receptor (NPY) antagonistic activities and are useful as agents for the treatment of various diseases related to NPY, for example, cardiovascular disorders, central nervous system disorders, metobolic diseases and the like.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language dan
recordid cdi_epo_espacenet_DK1204663TT3
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Hidtil ukendte spiroforbindelser med neuropeptid Y antagonistaktivitet
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T16%3A41%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KANATANI,%20AKIO%20BANYU%20PHARMACEUTICAL%20CO.%20LTD&rft.date=2004-02-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK1204663TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true